Business
Currency:USD
2023/FY
Stock NameRevenueRatio
Vaxcyte101.3M65.90%
Astellas Pharma Inc. (Astellas)33.99M22.11%
Tasly Biopharmaceuticals Co., Ltd. (Tasly)6.97M4.53%
Merck Sharp & Dohme Corporation (Merck)5.87M3.82%
Bristol Myers Squibb Company (BMS)5.59M3.64%
Merck KGaA, Darmstadt, Germany8K0.01%
View all
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States153.73M100.00%